Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hayek

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|April 1, 1993
Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control miceT Hayek, Y Ito, N Azrolan, et al.
Annals of the New York Academy of Sciences|April 15, 1997
Cholesteryl ester transfer protein and atherogenesisA Tall, D Sharp, S Zhong, et al.
The Journal of Clinical Investigation|October 1, 1995
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgeneT Hayek, L Masucci-Magoulas, X Jiang, et al.
The American Journal of Clinical Nutrition|May 9, 2000
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient miceM Aviram, L Dornfeld, M Rosenblat, et al.
The Journal of Clinical Investigation|August 1, 1992
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levelsT Hayek, T Chajek-Shaul, A Walsh, et al.
Biochemical and Biophysical Research Communications|November 13, 1995
Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregatedM Aviram, I Maor, S Keidar, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1994
Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patientsN Azrolan, C D Brown, L Thomas, et al.
The Journal of Biological Chemistry|July 4, 1997
Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasmaS Levak-Frank, P H Weinstock, T Hayek, et al.
The Journal of Clinical Investigation|September 1, 1993
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic miceT Hayek, N Azrolan, R B Verdery, et al.
The Journal of Biological Chemistry|June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic miceL B Agellon, A Walsh, T Hayek, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|April 1, 1993
Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control miceT Hayek, Y Ito, N Azrolan, et al.
Annals of the New York Academy of Sciences|April 15, 1997
Cholesteryl ester transfer protein and atherogenesisA Tall, D Sharp, S Zhong, et al.
The Journal of Clinical Investigation|October 1, 1995
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgeneT Hayek, L Masucci-Magoulas, X Jiang, et al.
The American Journal of Clinical Nutrition|May 9, 2000
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient miceM Aviram, L Dornfeld, M Rosenblat, et al.
The Journal of Clinical Investigation|August 1, 1992
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levelsT Hayek, T Chajek-Shaul, A Walsh, et al.
Biochemical and Biophysical Research Communications|November 13, 1995
Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregatedM Aviram, I Maor, S Keidar, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1994
Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patientsN Azrolan, C D Brown, L Thomas, et al.
The Journal of Biological Chemistry|July 4, 1997
Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasmaS Levak-Frank, P H Weinstock, T Hayek, et al.
The Journal of Clinical Investigation|September 1, 1993
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic miceT Hayek, N Azrolan, R B Verdery, et al.
The Journal of Biological Chemistry|June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic miceL B Agellon, A Walsh, T Hayek, et al.
Pageof 7